Jason C. Chandler
- Oncology top 5%
- Pulmonary and Respiratory Medicine top 5%
- Immunology top 10%
- Molecular Biology
- Hematology top 5%
- Co-authors
- David R. SpigelJames L. GulleyNicholas IannottiAnja von HeydebreckKaren KellyDavid WaterhouseDing WangArun Rajan
- Topics
- Cancer Immunotherapy and Biomarkers (13 papers)Chronic Lymphocytic Leukemia Research (11 papers)Lymphoma Diagnosis and Treatment (9 papers)
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
Jason C. Chandler
39 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 63
- Oncology 742
- Pulmonary and Respiratory Medicine 453
- Immunology 246
- Molecular Biology 186
- Hematology 157
Countries citing papers authored by Jason C. Chandler
This map shows the geographic impact of Jason C. Chandler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jason C. Chandler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jason C. Chandler more than expected).
Fields of papers citing papers by Jason C. Chandler
This network shows the impact of papers produced by Jason C. Chandler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jason C. Chandler. The network helps show where Jason C. Chandler may publish in the future.
Co-authorship network of co-authors of Jason C. Chandler
This figure shows the co-authorship network connecting the top 25 collaborators of Jason C. Chandler. A scholar is included among the top collaborators of Jason C. Chandler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jason C. Chandler. Jason C. Chandler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 39 | |
| 3 | 66 | |
| 4 | 13 | |
| 5 | 178 | |
| 6 | 5 | |
| 7 | 39 | |
| 8 | 225 | |
| 9 | 76 | |
| 10 | Safety of avelumab (MSB0010718C), an anti-PD-L1 antibody : updated analysis from the phase Ib JAVELIN solid tumor trial | 1 |
| 11 | 29 | |
| 12 | 4 | |
| 13 | 11 | |
| 14 | 7 | |
| 15 | 1 | |
| 16 | 1 | |
| 17 | 3 | |
| 18 | 71 | |
| 19 | 5 | |
| 20 | 34 |
About Jason C. Chandler
Jason C. Chandler is a scholar working on Genetics, Oncology and Hematology, having authored 41 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (13 papers), Chronic Lymphocytic Leukemia Research (11 papers) and Lymphoma Diagnosis and Treatment (9 papers). The work is most often cited by research in Oncology (742 citations), Hematology (157 citations) and Pulmonary and Respiratory Medicine (453 citations). Jason C. Chandler has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include David R. Spigel, James L. Gulley, Nicholas Iannotti, Anja von Heydebreck, Karen Kelly, David Waterhouse, Ding Wang, Arun Rajan, Kevin M. Chin and Robert M. Jotte. Their work appears in journals such as Journal of Clinical Oncology, Blood and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.